Brevan Howard Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$264K Sell
28,227
-32,110
-53% -$301K ﹤0.01% 1508
2025
Q1
$741K Buy
60,337
+46,266
+329% +$568K 0.01% 558
2024
Q4
$186K Sell
14,071
-8,614
-38% -$114K ﹤0.01% 891
2024
Q3
$437K Buy
+22,685
New +$437K ﹤0.01% 668